Paper4841969
Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.
Liotta LA and 2 others. Cancer Res, 1974. Cited by 720 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Papers, record 4841969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4841969
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Vessels | Major topic |
| Cell Count | Major topic |
| Disease Models, Animal | Major topic |
| Fibrosarcoma | Major topic |
| Lung Neoplasms | Major topic |
| Neoplasm Metastasis | Major topic |
| Animals | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Neoplasm Transplantation | |
| Perfusion | |
| Sarcoma, Experimental | |
| Time Factors | |
| Transplantation, Homologous |
Source PubMed
Cited by183
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 720 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,582,724 | Role of circulating tumor cell clusters in breast cancer. | Transl Breast Cancer Res | 2026 | https://conductscience.org/library/papers/42582724 | PubMed |
| 41,224,972 | Neutrophil extracellular traps in cancer. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/41224972 | PubMed |
| 40,753,165 | Pericytes promote metastasis by regulating tumor local vascular tone and hemodynamics. | Nat Commun | 2025 | https://conductscience.org/library/papers/40753165 | PubMed |
| 40,176,031 | EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanisms. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40176031 | PubMed |
| 38,601,447 | Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review. | Transl Lung Cancer Res | 2024 | https://conductscience.org/library/papers/38601447 | PubMed |
| 36,059,616 | A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis. | Front Oncol | 2022 | https://conductscience.org/library/papers/36059616 | PubMed |
| 35,670,186 | Lymphovascular invasion: A non-sized T descriptor for stage IA non-small cell lung cancer. | Thorac Cancer | 2022 | https://conductscience.org/library/papers/35670186 | PubMed |
| 35,582,592 | Role of circulating tumor cell spheroids in drug resistance. | Cancer Drug Resist | 2019 | https://conductscience.org/library/papers/35582592 | PubMed |
| 35,092,563 | The dark side of miracle plant-Aloe vera: a review. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/35092563 | PubMed |
| 34,511,488 | Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study. | Cancer Biomark | 2022 | https://conductscience.org/library/papers/34511488 | PubMed |
| 34,503,281 | Blood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503281 | PubMed |
| 33,883,980 | Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer. | EXCLI J | 2021 | https://conductscience.org/library/papers/33883980 | PubMed |
| 33,101,929 | Full three-dimensional segmentation and quantification of tumor vessels for photoacoustic images. | Photoacoustics | 2020 | https://conductscience.org/library/papers/33101929 | PubMed |
| 33,006,977 | A mathematical model of the metastatic bottleneck predicts patient outcome and response to cancer treatment. | PLoS Comput Biol | 2020 | https://conductscience.org/library/papers/33006977 | PubMed |
| 32,747,891 | Microfluidic endothelium-on-a-chip development, from in vivo to in vitro experimental models. | Rom J Morphol Embryol | 2020 | https://conductscience.org/library/papers/32747891 | PubMed |
| 32,720,039 | Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary Breast Cancer Suggests an Orderly Spread Through the Regional Lymph Nodes. | Ann Surg Oncol | 2020 | https://conductscience.org/library/papers/32720039 | PubMed |
| 32,675,540 | Casting A Wide Net On Surgery: The Central Role of Neutrophil Extracellular Traps. | Ann Surg | 2020 | https://conductscience.org/library/papers/32675540 | PubMed |
| 32,542,176 | Automated in vivo Assessment of Vascular Response to Radiation using a Hybrid Theranostic X-ray Irradiator/Fluorescence Molecular Imaging System. | IEEE Access | 2020 | https://conductscience.org/library/papers/32542176 | PubMed |
| 32,539,869 | TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients. | J Exp Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32539869 | PubMed |
| 32,365,530 | Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32365530 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4841969
GET https://conductscience.org/api/papers/v1/4841969/cited_by?page=2